Rare, rarer, lung involvement in adult-onset Still's disease: A mini-review

被引:4
|
作者
Nies, Jasper F. F. [1 ]
Schneider, Udo [2 ]
Krusche, Martin [3 ]
机构
[1] Univ Med Ctr Cologne, Internal Med 2, Cologne, Germany
[2] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany
[3] Univ Med Ctr Hamburg Eppendorf, Dept Nephrol Rheumatol & Endocrinol, Hamburg, Germany
关键词
adult-onset Still's disease (AOSD); interstitial lung disease; pulmonary arterial hypertension; IL-6; blocking; IL-1; PULMONARY ARTERIAL-HYPERTENSION; JUVENILE IDIOPATHIC ARTHRITIS; CYTOKINE; PATIENT; CELLS; MANIFESTATIONS; EPIDEMIOLOGY; PATHOGENESIS; SAFETY; IL-1;
D O I
10.3389/fmed.2022.989777
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adult-onset Still's disease (AOSD) is a polygenic systemic autoinflammatory disease which is associated with increased morbidity and mortality. Pulmonary involvement is a rare, but serious complication of AOSD. As in AOSD, IL-1b, IL-18, and IL-6 dominate the molecular pathogenesis, which mediate a type 1 and type 3 inflammatory signature of the adaptive immune system. This is evidenced by the success of IL-1- and IL-6 inhibition in the management of AOSD. However, anaphylactic reactions to treatment with IL-1- or IL-6-inhibitors is currently being discussed as a potential trigger for lung involvement inf AOSD, while genetic risk factors have also been identified. Clinically, pulmonary involvement in AOSD can manifest in many different forms. Parenchymal inflammation with peripheral consolidations is the most frequent form while PAH is less common, but often very difficult to manage. This mini-review provides an overview of the pathophysiology as well as the clinical presentation and the diagnostic features of pulmonary involvement in AOSD.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Parenchymal lung involvement in adult-onset Still disease A STROBE-compliant case series and literature review
    Gerfaud-Valentin, Mathieu
    Cottin, Vincent
    Jamilloux, Yvan
    Hot, Arnaud
    Gaillard-Coadon, Agathe
    Durieu, Isabelle
    Broussolle, Christiane
    Iwaz, Jean
    Seve, Pascal
    MEDICINE, 2016, 95 (30)
  • [2] Adult-onset Still's disease complications
    Fauter, M.
    Gerfaud-Valentin, M.
    Delplanque, M.
    Georgin-Lavialle, S.
    Seve, P.
    Jamilloux, Y.
    REVUE DE MEDECINE INTERNE, 2020, 41 (03): : 168 - 179
  • [3] Adult-onset Still's disease
    Bagnari, Valentina
    Colina, Matteo
    Ciancio, Giovanni
    Govoni, Marcello
    Trotta, Francesco
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (07) : CP9 - 862
  • [4] Adult-onset Still's disease
    Castaneda, Santos
    Vicente, Esther F.
    Gonzalez-Gay, Miguel A.
    MEDICINA CLINICA, 2016, 147 (05): : 217 - 222
  • [5] Cardio-respiratory involvement in adult-onset Still's disease
    Lethrosne, C.
    Pernot, B.
    Diot, P.
    Diot, E.
    REVUE DES MALADIES RESPIRATOIRES, 2013, 30 (04) : 262 - 271
  • [6] Complications of adult-onset Still's disease and their management
    Mitrovic, Stephane
    Fautrel, Bruno
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (05) : 351 - 365
  • [7] Biologics for the treatment of adult-onset still's disease
    Yoo, Dae Hyun
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (11) : 1173 - 1190
  • [8] Anakinra for the treatment of adult-onset Still's disease
    Castaneda, Santos
    Atienza-Mateo, Belen
    Martin-Varillas, Jose L.
    Serra Lopez-Matencio, Jose M.
    Gonzalez-Gay, Miguel A.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (12) : 979 - 992
  • [9] Canakinumab for the treatment of adult-onset Still's disease
    Sfriso, Paolo
    Bindoli, Sara
    Doria, Andrea
    Feist, Eugen
    Galozzi, Paola
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (02) : 129 - 138
  • [10] Life-threatening complications of adult-onset Still's disease
    Efthimiou, Petros
    Kadavath, Sabeeda
    Mehta, Bella
    CLINICAL RHEUMATOLOGY, 2014, 33 (03) : 305 - 314